Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/300254 stock hub

SHE/300254 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300254is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.6B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300254

In the news

Latest news · SHE/300254

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E167.7

P25 23.5P50 41.3P75 83.2

ROE7.8

P25 -0.9P50 4.1P75 8.8

ROIC5.4

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300254 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

215

Groups with data

Currency

CNY

Showing 215 of 215 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	1,196
Employees Change	-38%
Employees Change Percent	-3.08
Enterprise value	CNY 3.9B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE1000016D0
Last refreshed	2026-05-10
Market cap	CNY 3.6B
Price	CNY 13.97
Price currency	CNY
Rev Per Employee	710,086.9x
Sector	Healthcare
Sic	2834
Symbol	she/300254
Website	https://www.cy-pharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.57%
EV Earnings	191.83x
EV/EBIT	51.47x
EV/EBITDA	29.54x
EV/FCF	60.85x
EV/Sales	4.6x
FCF yield	1.79%
P/B ratio	6.2x
P/E ratio	167.69x
P/S ratio	4.21x
PE Ratio10 Y	123.31x
PE Ratio3 Y	89.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.94%
EBITDA Margin	14.78%
FCF margin	7.56%
Gross margin	67.08%
Gross Profit	CNY 569.7M
Gross Profit Growth	1.52%
Gross Profit Growth Q	-25.17%
Gross Profit Growth3 Y	-0.12%
Gross Profit Growth5 Y	-1.87%
Net Income	CNY 20.4M
Net Income Growth	-75.48%
Net Income Growth Years	0%
Pretax Margin	9.96%
Profit Margin	2.4%
Profit Per Employee	CNY 17,027
Profitable Years	3
ROA	3.08
Roa5y	-1.04
ROCE	7.71
ROE	7.85
Roe5y	-7.25
ROIC	5.36
Roic5y	-2.95

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-2.77%
Cagr1y	54.07%
Cagr3y	30.46%
Cagr5y	15.46%
Div CAGR3	-26.32%
Div CAGR5	-32.13%
EPS Growth	-75.75
EPS Growth Years	0
FCF Growth	401.12%
FCF Growth Q	-25.16%
FCF Growth3 Y	16.31%
OCF Growth	-7.52%
OCF Growth Q	168.2%
OCF Growth10 Y	6.92%
OCF Growth3 Y	0.57%
OCF Growth5 Y	24.93%
Revenue Growth	1.57x
Revenue Growth Q	-26.91x
Revenue Growth Years	2x
Revenue Growth3 Y	0.1x
Revenue Growth5 Y	-0.28x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.55
Assets	CNY 1.5B
Cash	CNY 129M
Current Assets	CNY 563.6M
Current Liabilities	CNY 572.4M
Debt	CNY 526.3M
Debt EBITDA	CNY 3.98
Debt Equity	CNY 0.91
Debt FCF	CNY 8.2
Equity	CNY 577.1M
Interest Coverage	3.41
Liabilities	CNY 972.7M
Long Term Assets	CNY 986.1M
Long Term Liabilities	CNY 400.3M
Net Cash	CNY -397.3M
Net Cash By Market Cap	CNY -11.11
Net Debt EBITDA	CNY 3.17
Net Debt Equity	CNY 0.69
Net Debt FCF	CNY 6.19
Tangible Book Value	CNY -191.8M
Tangible Book Value Per Share	CNY -0.75
WACC	6.66

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.92
Inventory Turnover	2.21
Net Working Capital	CNY 131.1M
Quick ratio	0.62
Working Capital	CNY -47.5M
Working Capital Turnover	CNY -21.58

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.13%
Dividend per share	CNY 0
Last Dividend	CNY 0.02
Payout Ratio	90.75%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-24.51%
1Y total return	54.02%
200-day SMA	11.28
3Y total return	122.1%
50-day SMA	12.05
50-day SMA vs 200-day SMA	50over200
5Y total return	105.14%
All Time High	54.57
All Time High Change	-74.4%
All Time High Date	2015-06-15
All Time Low	4.92
All Time Low Change	183.94%
All Time Low Date	2021-02-08
ATR	0.68
Beta	0.54
Beta1y	0.2
Beta2y	0.55
Ch YTD	38.04
High	14.76
High52	15.01
High52 Date	2026-05-07
High52ch	-6.93%
Low	13.77
Low52	8.93
Low52 Date	2025-05-15
Low52ch	56.44%
Ma50ch	15.97%
Price vs 200-day SMA	23.86%
RSI	65.51
RSI Monthly	64.22
RSI Weekly	69.78
Sharpe ratio	1.01x
Sortino ratio	1.82
Total Return	-1.13%
Tr YTD	38.04
Tr1m	22.76%
Tr1w	-4.84%
Tr3m	18.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 75.9M
Operating Income Growth	7.6
Operating Income Growth Q	75.53
Operating margin	8.94

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	217,042,330%
Net Borrowing	67,585,302
Shares Insiders	15.24%
Shares Institutions	2.33%
Shares Out	256,058,563
Shares Qo Q	-3.58%
Shares Yo Y	1.13%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 64.2M
Average Volume	18,033,362.9x
Bv Per Share	1.15
CAPEX	CNY -19.1M
Ch10y	-25.56
Ch1m	22.76
Ch1w	-4.84
Ch1y	54.02
Ch3m	18.59
Ch3y	122.1
Ch5y	105.1
Ch6m	30.32
Change	-1.96%
Change From Open	-2.31
Close	14.25
Days Gap	0.35
Depreciation Amortization	49,593,536
Dollar Volume	229,893,114
Earnings Date	2026-04-28
EBIT	CNY 75.9M
EBITDA	CNY 125.5M
EPS	CNY 0.08
F Score	5
FCF	CNY 64.2M
FCF EV Yield	1.64x
FCF Per Share	CNY 0.25
Financing CF	146,926,472
Fiscal Year End	December
Founded	2,005
Goodwill	311,990,498
Graham Number	1.46725
Graham Upside	-89.5
Income Tax	CNY 28.5M
Investing CF	-277,709,427
Is Primary Listing	1
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Last Split Date	2016-07-08
Last Split Type	Forward
Ma150	11.16
Ma150ch	25.17%
Ma20	12.44
Ma20ch	12.3%
Net CF	-47,502,490
Next Earnings Date	2026-08-27
Open	14.3
P FCF Ratio	55.72
P OCF Ratio	42.95
Position In Range	20.2
Ppne	283,187,124
Price Date	2026-05-08
Price EBITDA	CNY 28.51
Relative Volume	0.93x
Revenue	849,263,936x
Tax By Revenue	3.36x
Tax Rate	33.72%
Tr6m	30.32%
Volume	16,456,200

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does SHE/300254 pay a dividend?

Capital-return profile for this ticker.

Performance

SHE/300254 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300254?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.3%

Share of float held by funds and institutions

Insider ownership

+15.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.1%

Negative means the company is buying back shares.

Technical

SHE/300254 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

65.5

Neutral momentum band

Price vs 200-day MA

+23.9%

50/200-day relationship not available

Beta (5Y)

0.54

Less volatile than the market

Sharpe ratio

1.01

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300254

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300254 stock rating?

she/300254 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300254 analysis?

The full report lives at /stocks/she/300254/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300254?

The latest report frames she/300254 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300254 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.